Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

Scientists have unveiled insights into how HIV-1, the virus responsible for AIDS, skillfully hijacks cellular machinery for its own survival. By dissecting the molecular interplay between the virus ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how to design a vaccine ...

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, ...

For some HIV vaccines, repetitive immunizations lead to a chain reaction of antibody production against immune complexes ...

Repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus ...

ACACIA Study Is Evaluating Two Long-Acting Broadly Neutralizing Antibodies Given at HIV Treatment InitiationLOS ANGELES, Jan.

A new campaign to address misconceptions and reduce stigma around HIV in Ireland has been launched by the HSE.